KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation

Youl Nam Lee, Stephanie Brandal, Pierre Noel, Erik Wentzel, Joshua T. Mendell, Michael A. McDevitt, Reuben Kapur, Melody Carter, Dean D. Metcalfe, Clifford M. Takemoto

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Activating mutations in codon D816 of the tyrosine kinase receptor, KIT, are found in the majority of patients with systemic mastocytosis. We found that the transcription factor, microphthalmia-associated transcription factor (MITF), is highly expressed in bone marrow biopsies from 9 of 10 patients with systemic mastocytosis and activating c-KIT mutations. In primary and transformed mast cells, we show that KIT signaling markedly up-regulates MITF protein. We demonstrate that MITF is required for the proliferative phenotype by inhibiting colony-forming units with sh-RNA knockdown of MITF. Furthermore, constitutively active KIT does not restore growth of primary MITF-deficient mast cells. MITF mRNA levels do not change significantly with KIT signaling, suggesting posttranscriptional regulation. An array screen from mast cells identified candidate miRNAs regulated by KIT signaling. We found that miR-539 and miR-381 are downregulated by KIT signaling and they repressed MITF expression through conserved miRNA binding sites in the MITF 3′-untranslated region. Forced expression of these miRNAs suppressed MITF protein and inhibited colony-forming capacity of mastocytosis cell lines. This work demonstrates a novel regulatory pathway between 2 critical mast cell factors, KIT and MITF, mediated by miRNAs; dysregulation of this pathway may contribute to abnormal mast cell proliferation and malignant mast cell diseases.

Original languageEnglish (US)
Pages (from-to)3629-3640
Number of pages12
JournalBlood
Volume117
Issue number13
DOIs
StatePublished - Mar 31 2011

Fingerprint

Microphthalmia-Associated Transcription Factor
Cell proliferation
MicroRNAs
Mast Cells
Cell Proliferation
Systemic Mastocytosis
Mastocytosis
Transcription Factor 3
Transcription factors
Biopsy
Mutation
Receptor Protein-Tyrosine Kinases
3' Untranslated Regions
Codon
Bone
Proteins

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Lee, Y. N., Brandal, S., Noel, P., Wentzel, E., Mendell, J. T., McDevitt, M. A., ... Takemoto, C. M. (2011). KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation. Blood, 117(13), 3629-3640. https://doi.org/10.1182/blood-2010-07-293548

KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation. / Lee, Youl Nam; Brandal, Stephanie; Noel, Pierre; Wentzel, Erik; Mendell, Joshua T.; McDevitt, Michael A.; Kapur, Reuben; Carter, Melody; Metcalfe, Dean D.; Takemoto, Clifford M.

In: Blood, Vol. 117, No. 13, 31.03.2011, p. 3629-3640.

Research output: Contribution to journalArticle

Lee, YN, Brandal, S, Noel, P, Wentzel, E, Mendell, JT, McDevitt, MA, Kapur, R, Carter, M, Metcalfe, DD & Takemoto, CM 2011, 'KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation', Blood, vol. 117, no. 13, pp. 3629-3640. https://doi.org/10.1182/blood-2010-07-293548
Lee, Youl Nam ; Brandal, Stephanie ; Noel, Pierre ; Wentzel, Erik ; Mendell, Joshua T. ; McDevitt, Michael A. ; Kapur, Reuben ; Carter, Melody ; Metcalfe, Dean D. ; Takemoto, Clifford M. / KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation. In: Blood. 2011 ; Vol. 117, No. 13. pp. 3629-3640.
@article{1a59df655ff84a0aa8966dd38fb62882,
title = "KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation",
abstract = "Activating mutations in codon D816 of the tyrosine kinase receptor, KIT, are found in the majority of patients with systemic mastocytosis. We found that the transcription factor, microphthalmia-associated transcription factor (MITF), is highly expressed in bone marrow biopsies from 9 of 10 patients with systemic mastocytosis and activating c-KIT mutations. In primary and transformed mast cells, we show that KIT signaling markedly up-regulates MITF protein. We demonstrate that MITF is required for the proliferative phenotype by inhibiting colony-forming units with sh-RNA knockdown of MITF. Furthermore, constitutively active KIT does not restore growth of primary MITF-deficient mast cells. MITF mRNA levels do not change significantly with KIT signaling, suggesting posttranscriptional regulation. An array screen from mast cells identified candidate miRNAs regulated by KIT signaling. We found that miR-539 and miR-381 are downregulated by KIT signaling and they repressed MITF expression through conserved miRNA binding sites in the MITF 3′-untranslated region. Forced expression of these miRNAs suppressed MITF protein and inhibited colony-forming capacity of mastocytosis cell lines. This work demonstrates a novel regulatory pathway between 2 critical mast cell factors, KIT and MITF, mediated by miRNAs; dysregulation of this pathway may contribute to abnormal mast cell proliferation and malignant mast cell diseases.",
author = "Lee, {Youl Nam} and Stephanie Brandal and Pierre Noel and Erik Wentzel and Mendell, {Joshua T.} and McDevitt, {Michael A.} and Reuben Kapur and Melody Carter and Metcalfe, {Dean D.} and Takemoto, {Clifford M.}",
year = "2011",
month = "3",
day = "31",
doi = "10.1182/blood-2010-07-293548",
language = "English (US)",
volume = "117",
pages = "3629--3640",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

TY - JOUR

T1 - KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation

AU - Lee, Youl Nam

AU - Brandal, Stephanie

AU - Noel, Pierre

AU - Wentzel, Erik

AU - Mendell, Joshua T.

AU - McDevitt, Michael A.

AU - Kapur, Reuben

AU - Carter, Melody

AU - Metcalfe, Dean D.

AU - Takemoto, Clifford M.

PY - 2011/3/31

Y1 - 2011/3/31

N2 - Activating mutations in codon D816 of the tyrosine kinase receptor, KIT, are found in the majority of patients with systemic mastocytosis. We found that the transcription factor, microphthalmia-associated transcription factor (MITF), is highly expressed in bone marrow biopsies from 9 of 10 patients with systemic mastocytosis and activating c-KIT mutations. In primary and transformed mast cells, we show that KIT signaling markedly up-regulates MITF protein. We demonstrate that MITF is required for the proliferative phenotype by inhibiting colony-forming units with sh-RNA knockdown of MITF. Furthermore, constitutively active KIT does not restore growth of primary MITF-deficient mast cells. MITF mRNA levels do not change significantly with KIT signaling, suggesting posttranscriptional regulation. An array screen from mast cells identified candidate miRNAs regulated by KIT signaling. We found that miR-539 and miR-381 are downregulated by KIT signaling and they repressed MITF expression through conserved miRNA binding sites in the MITF 3′-untranslated region. Forced expression of these miRNAs suppressed MITF protein and inhibited colony-forming capacity of mastocytosis cell lines. This work demonstrates a novel regulatory pathway between 2 critical mast cell factors, KIT and MITF, mediated by miRNAs; dysregulation of this pathway may contribute to abnormal mast cell proliferation and malignant mast cell diseases.

AB - Activating mutations in codon D816 of the tyrosine kinase receptor, KIT, are found in the majority of patients with systemic mastocytosis. We found that the transcription factor, microphthalmia-associated transcription factor (MITF), is highly expressed in bone marrow biopsies from 9 of 10 patients with systemic mastocytosis and activating c-KIT mutations. In primary and transformed mast cells, we show that KIT signaling markedly up-regulates MITF protein. We demonstrate that MITF is required for the proliferative phenotype by inhibiting colony-forming units with sh-RNA knockdown of MITF. Furthermore, constitutively active KIT does not restore growth of primary MITF-deficient mast cells. MITF mRNA levels do not change significantly with KIT signaling, suggesting posttranscriptional regulation. An array screen from mast cells identified candidate miRNAs regulated by KIT signaling. We found that miR-539 and miR-381 are downregulated by KIT signaling and they repressed MITF expression through conserved miRNA binding sites in the MITF 3′-untranslated region. Forced expression of these miRNAs suppressed MITF protein and inhibited colony-forming capacity of mastocytosis cell lines. This work demonstrates a novel regulatory pathway between 2 critical mast cell factors, KIT and MITF, mediated by miRNAs; dysregulation of this pathway may contribute to abnormal mast cell proliferation and malignant mast cell diseases.

UR - http://www.scopus.com/inward/record.url?scp=79953721454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953721454&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-07-293548

DO - 10.1182/blood-2010-07-293548

M3 - Article

VL - 117

SP - 3629

EP - 3640

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -